nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ABCB1—peripheral nervous system neoplasm	0.356	1	CbGaD
Ergotamine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0427	0.135	CbGbCtD
Ergotamine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0373	0.118	CbGbCtD
Ergotamine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0373	0.118	CbGbCtD
Ergotamine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0341	0.108	CbGbCtD
Ergotamine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0259	0.0817	CbGbCtD
Ergotamine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0224	0.0706	CbGbCtD
Ergotamine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0208	0.0656	CbGbCtD
Ergotamine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0167	0.0527	CbGbCtD
Ergotamine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0159	0.0503	CbGbCtD
Ergotamine—HTR1D—meninx—peripheral nervous system neoplasm	0.0151	0.113	CbGeAlD
Ergotamine—HTR1F—trigeminal nerve—peripheral nervous system neoplasm	0.0151	0.113	CbGeAlD
Ergotamine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0149	0.0469	CbGbCtD
Ergotamine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0146	0.0461	CbGbCtD
Ergotamine—HTR1B—dura mater—peripheral nervous system neoplasm	0.0143	0.108	CbGeAlD
Ergotamine—HTR1D—dura mater—peripheral nervous system neoplasm	0.0139	0.104	CbGeAlD
Ergotamine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00996	0.0314	CbGbCtD
Ergotamine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00955	0.0301	CbGbCtD
Ergotamine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00875	0.0276	CbGbCtD
Ergotamine—Distress—Tretinoin—peripheral nervous system neoplasm	0.00844	0.0566	CcSEcCtD
Ergotamine—Distress—Isotretinoin—peripheral nervous system neoplasm	0.00844	0.0566	CcSEcCtD
Ergotamine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00811	0.061	CbGeAlD
Ergotamine—Ischaemia—Isotretinoin—peripheral nervous system neoplasm	0.00642	0.043	CcSEcCtD
Ergotamine—Ischaemia—Tretinoin—peripheral nervous system neoplasm	0.00642	0.043	CcSEcCtD
Ergotamine—Distress—Alitretinoin—peripheral nervous system neoplasm	0.0064	0.0429	CcSEcCtD
Ergotamine—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00617	0.0463	CbGeAlD
Ergotamine—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00597	0.0449	CbGeAlD
Ergotamine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00597	0.0188	CbGbCtD
Ergotamine—Emotional distress—Isotretinoin—peripheral nervous system neoplasm	0.00551	0.0369	CcSEcCtD
Ergotamine—Emotional distress—Tretinoin—peripheral nervous system neoplasm	0.00551	0.0369	CcSEcCtD
Ergotamine—HTR1F—ganglion—peripheral nervous system neoplasm	0.00543	0.0408	CbGeAlD
Ergotamine—Ischaemia—Alitretinoin—peripheral nervous system neoplasm	0.00487	0.0326	CcSEcCtD
Ergotamine—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00439	0.033	CbGeAlD
Ergotamine—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00425	0.032	CbGeAlD
Ergotamine—Emotional distress—Alitretinoin—peripheral nervous system neoplasm	0.00418	0.028	CcSEcCtD
Ergotamine—Cyanosis—Isotretinoin—peripheral nervous system neoplasm	0.00331	0.0222	CcSEcCtD
Ergotamine—Cyanosis—Tretinoin—peripheral nervous system neoplasm	0.00331	0.0222	CcSEcCtD
Ergotamine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00297	0.0223	CbGeAlD
Ergotamine—Numbness—Tretinoin—peripheral nervous system neoplasm	0.00283	0.0189	CcSEcCtD
Ergotamine—Numbness—Isotretinoin—peripheral nervous system neoplasm	0.00283	0.0189	CcSEcCtD
Ergotamine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00277	0.0208	CbGeAlD
Ergotamine—Sensory loss—Tretinoin—peripheral nervous system neoplasm	0.0027	0.0181	CcSEcCtD
Ergotamine—Sensory loss—Isotretinoin—peripheral nervous system neoplasm	0.0027	0.0181	CcSEcCtD
Ergotamine—Cyanosis—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.0168	CcSEcCtD
Ergotamine—HTR1B—ganglion—peripheral nervous system neoplasm	0.00222	0.0167	CbGeAlD
Ergotamine—HTR1D—ganglion—peripheral nervous system neoplasm	0.00215	0.0162	CbGeAlD
Ergotamine—Numbness—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.0144	CcSEcCtD
Ergotamine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00213	0.016	CbGeAlD
Ergotamine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00211	0.0159	CbGeAlD
Ergotamine—HTR2A—pons—peripheral nervous system neoplasm	0.00209	0.0157	CbGeAlD
Ergotamine—Numbness—Vincristine—peripheral nervous system neoplasm	0.00206	0.0138	CcSEcCtD
Ergotamine—Sensory loss—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.0137	CcSEcCtD
Ergotamine—HTR1E—brainstem—peripheral nervous system neoplasm	0.00204	0.0154	CbGeAlD
Ergotamine—Sensory loss—Vincristine—peripheral nervous system neoplasm	0.00198	0.0132	CcSEcCtD
Ergotamine—Cyanosis—Etoposide—peripheral nervous system neoplasm	0.00196	0.0131	CcSEcCtD
Ergotamine—SLC6A2—nerve—peripheral nervous system neoplasm	0.0018	0.0135	CbGeAlD
Ergotamine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00179	0.0135	CbGeAlD
Ergotamine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00178	0.0134	CbGeAlD
Ergotamine—Numbness—Etoposide—peripheral nervous system neoplasm	0.00167	0.0112	CcSEcCtD
Ergotamine—DRD2—nerve—peripheral nervous system neoplasm	0.00164	0.0123	CbGeAlD
Ergotamine—DRD2—ganglion—peripheral nervous system neoplasm	0.00162	0.0122	CbGeAlD
Ergotamine—Sensory loss—Etoposide—peripheral nervous system neoplasm	0.0016	0.0107	CcSEcCtD
Ergotamine—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.00118	0.00791	CcSEcCtD
Ergotamine—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00785	CcSEcCtD
Ergotamine—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00785	CcSEcCtD
Ergotamine—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00109	0.00821	CbGeAlD
Ergotamine—HTR2A—nerve—peripheral nervous system neoplasm	0.00108	0.00814	CbGeAlD
Ergotamine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00107	0.00804	CbGeAlD
Ergotamine—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00106	0.00795	CbGeAlD
Ergotamine—Dihydroergotamine—ABCB1—peripheral nervous system neoplasm	0.00102	0.415	CrCbGaD
Ergotamine—HTR1B—brainstem—peripheral nervous system neoplasm	0.000967	0.00726	CbGeAlD
Ergotamine—HTR1D—brainstem—peripheral nervous system neoplasm	0.000936	0.00703	CbGeAlD
Ergotamine—Ergonovine—ABCB1—peripheral nervous system neoplasm	0.000933	0.379	CrCbGaD
Ergotamine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000927	0.00696	CbGeAlD
Ergotamine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000887	0.00595	CcSEcCtD
Ergotamine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000884	0.00593	CcSEcCtD
Ergotamine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000884	0.00593	CcSEcCtD
Ergotamine—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000879	0.00589	CcSEcCtD
Ergotamine—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000872	0.00584	CcSEcCtD
Ergotamine—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000872	0.00584	CcSEcCtD
Ergotamine—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000861	0.00577	CcSEcCtD
Ergotamine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000855	0.00573	CcSEcCtD
Ergotamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000816	0.00547	CcSEcCtD
Ergotamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000816	0.00547	CcSEcCtD
Ergotamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000805	0.0054	CcSEcCtD
Ergotamine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00078	0.00586	CbGeAlD
Ergotamine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000774	0.00518	CcSEcCtD
Ergotamine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000773	0.00581	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000768	0.00515	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000762	0.0051	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000762	0.0051	CcSEcCtD
Ergotamine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000757	0.00507	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000752	0.00504	CcSEcCtD
Ergotamine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000751	0.00503	CcSEcCtD
Ergotamine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000751	0.00503	CcSEcCtD
Ergotamine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000741	0.00497	CcSEcCtD
Ergotamine—Pain—Topotecan—peripheral nervous system neoplasm	0.000721	0.00483	CcSEcCtD
Ergotamine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000719	0.0054	CbGeAlD
Ergotamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000715	0.00479	CcSEcCtD
Ergotamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000715	0.00479	CcSEcCtD
Ergotamine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000713	0.00478	CcSEcCtD
Ergotamine—Pain—Melphalan—peripheral nervous system neoplasm	0.000706	0.00473	CcSEcCtD
Ergotamine—DRD2—brainstem—peripheral nervous system neoplasm	0.000705	0.0053	CbGeAlD
Ergotamine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000693	0.00464	CcSEcCtD
Ergotamine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000672	0.0045	CcSEcCtD
Ergotamine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00067	0.00449	CcSEcCtD
Ergotamine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000661	0.00443	CcSEcCtD
Ergotamine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000646	0.00433	CcSEcCtD
Ergotamine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000637	0.00427	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000623	0.00417	CcSEcCtD
Ergotamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.00414	CcSEcCtD
Ergotamine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000618	0.00464	CbGeAlD
Ergotamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000605	0.00405	CcSEcCtD
Ergotamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0006	0.00402	CcSEcCtD
Ergotamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0006	0.00402	CcSEcCtD
Ergotamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000596	0.004	CcSEcCtD
Ergotamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000592	0.00397	CcSEcCtD
Ergotamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000591	0.00396	CcSEcCtD
Ergotamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000591	0.00396	CcSEcCtD
Ergotamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000584	0.00392	CcSEcCtD
Ergotamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000584	0.00391	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000577	0.00387	CcSEcCtD
Ergotamine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.00381	CcSEcCtD
Ergotamine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000563	0.00377	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000556	0.00373	CcSEcCtD
Ergotamine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000548	0.00367	CcSEcCtD
Ergotamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000544	0.00365	CcSEcCtD
Ergotamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000542	0.00363	CcSEcCtD
Ergotamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000536	0.00359	CcSEcCtD
Ergotamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000532	0.00356	CcSEcCtD
Ergotamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000532	0.00356	CcSEcCtD
Ergotamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000527	0.00353	CcSEcCtD
Ergotamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000525	0.00352	CcSEcCtD
Ergotamine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000523	0.00351	CcSEcCtD
Ergotamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000522	0.0035	CcSEcCtD
Ergotamine—Bromocriptine—ABCB1—peripheral nervous system neoplasm	0.000507	0.206	CrCbGaD
Ergotamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000501	0.00335	CcSEcCtD
Ergotamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.00333	CcSEcCtD
Ergotamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000497	0.00333	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000492	0.0033	CcSEcCtD
Ergotamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00049	0.00329	CcSEcCtD
Ergotamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00049	0.00328	CcSEcCtD
Ergotamine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000485	0.00325	CcSEcCtD
Ergotamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000483	0.00323	CcSEcCtD
Ergotamine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000465	0.00349	CbGeAlD
Ergotamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000462	0.00309	CcSEcCtD
Ergotamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000455	0.00305	CcSEcCtD
Ergotamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.003	CcSEcCtD
Ergotamine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000444	0.00298	CcSEcCtD
Ergotamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000438	0.00294	CcSEcCtD
Ergotamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.00291	CcSEcCtD
Ergotamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000423	0.00283	CcSEcCtD
Ergotamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.00272	CcSEcCtD
Ergotamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.0027	CcSEcCtD
Ergotamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000397	0.00266	CcSEcCtD
Ergotamine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000388	0.0026	CcSEcCtD
Ergotamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000388	0.0026	CcSEcCtD
Ergotamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000387	0.0026	CcSEcCtD
Ergotamine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000385	0.00289	CbGeAlD
Ergotamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00252	CcSEcCtD
Ergotamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00246	CcSEcCtD
Ergotamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000363	0.00243	CcSEcCtD
Ergotamine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.00241	CcSEcCtD
Ergotamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000355	0.00238	CcSEcCtD
Ergotamine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000355	0.00266	CbGeAlD
Ergotamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00035	0.00234	CcSEcCtD
Ergotamine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000348	0.00261	CbGeAlD
Ergotamine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000344	0.00259	CbGeAlD
Ergotamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000343	0.0023	CcSEcCtD
Ergotamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00215	CcSEcCtD
Ergotamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000314	0.00211	CcSEcCtD
Ergotamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00205	CcSEcCtD
Ergotamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000294	0.00197	CcSEcCtD
Ergotamine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00197	CcSEcCtD
Ergotamine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00194	CcSEcCtD
Ergotamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00189	CcSEcCtD
Ergotamine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00182	CcSEcCtD
Ergotamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00181	CcSEcCtD
Ergotamine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.00027	0.00203	CbGeAlD
Ergotamine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00179	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00169	CcSEcCtD
Ergotamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00168	CcSEcCtD
Ergotamine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00167	CcSEcCtD
Ergotamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00159	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00157	CcSEcCtD
Ergotamine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00154	CcSEcCtD
Ergotamine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000229	0.00172	CbGeAlD
Ergotamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00147	CcSEcCtD
Ergotamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00133	CcSEcCtD
Ergotamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00131	CcSEcCtD
Ergotamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00123	CcSEcCtD
Ergotamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00122	CcSEcCtD
Ergotamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Ergotamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000165	0.0011	CcSEcCtD
Ergotamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00109	CcSEcCtD
Ergotamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00102	CcSEcCtD
Ergotamine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.00015	0.00113	CbGeAlD
Ergotamine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.76e-05	0.000417	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.74e-05	0.000414	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000412	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.73e-05	0.000412	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.69e-05	0.000401	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.68e-05	0.0004	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.67e-05	0.000397	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.65e-05	0.000392	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.63e-05	0.000387	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	1.62e-05	0.000384	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.61e-05	0.000383	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.61e-05	0.000382	CbGpPWpGaD
Ergotamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000381	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.56e-05	0.000372	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.55e-05	0.000369	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.55e-05	0.000368	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000367	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.54e-05	0.000367	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.52e-05	0.000363	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.52e-05	0.000361	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	1.52e-05	0.000361	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.51e-05	0.00036	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.51e-05	0.000359	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.5e-05	0.000357	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.49e-05	0.000355	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.49e-05	0.000354	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.48e-05	0.000352	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.47e-05	0.000351	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.44e-05	0.000342	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.44e-05	0.000342	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.43e-05	0.000341	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.43e-05	0.00034	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	0.00034	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000331	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.39e-05	0.00033	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.38e-05	0.000328	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.37e-05	0.000326	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.37e-05	0.000325	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.000324	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000321	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.00032	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.34e-05	0.000319	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.33e-05	0.000315	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.000315	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.32e-05	0.000314	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.31e-05	0.000312	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.31e-05	0.000312	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000312	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.3e-05	0.00031	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.3e-05	0.000309	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000307	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.29e-05	0.000307	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.28e-05	0.000304	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.28e-05	0.000304	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000301	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.26e-05	0.0003	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000299	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.25e-05	0.000298	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000296	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.24e-05	0.000296	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000295	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000295	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000293	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.23e-05	0.000292	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000291	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.00029	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000289	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000289	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000286	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000284	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.19e-05	0.000282	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.16e-05	0.000276	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.16e-05	0.000275	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.15e-05	0.000274	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000271	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.13e-05	0.000269	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.13e-05	0.000269	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.000266	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000265	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.09e-05	0.000259	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000259	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.08e-05	0.000256	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000255	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.000254	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.06e-05	0.000251	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.05e-05	0.00025	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.00025	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000247	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.02e-05	0.000242	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	9.78e-06	0.000233	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.72e-06	0.000231	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.67e-06	0.00023	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.52e-06	0.000226	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.5e-06	0.000226	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	9.36e-06	0.000222	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.34e-06	0.000222	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.29e-06	0.000221	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.17e-06	0.000218	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.16e-06	0.000218	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.13e-06	0.000217	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.97e-06	0.000213	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.94e-06	0.000213	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.92e-06	0.000212	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.91e-06	0.000212	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.89e-06	0.000211	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.85e-06	0.00021	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.82e-06	0.00021	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.74e-06	0.000208	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.72e-06	0.000207	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.64e-06	0.000205	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.58e-06	0.000204	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.51e-06	0.000202	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.46e-06	0.000201	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.42e-06	0.0002	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	8.39e-06	0.000199	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.34e-06	0.000198	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.32e-06	0.000198	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	8.26e-06	0.000196	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.2e-06	0.000195	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.19e-06	0.000195	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.15e-06	0.000194	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.12e-06	0.000193	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.09e-06	0.000192	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.07e-06	0.000192	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.05e-06	0.000192	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.98e-06	0.00019	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.93e-06	0.000188	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.92e-06	0.000188	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.9e-06	0.000188	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.84e-06	0.000186	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.76e-06	0.000185	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.62e-06	0.000181	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.55e-06	0.00018	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.51e-06	0.000179	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.47e-06	0.000178	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.44e-06	0.000177	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.4e-06	0.000176	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.34e-06	0.000174	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.25e-06	0.000172	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.24e-06	0.000172	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.21e-06	0.000171	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.21e-06	0.000171	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.08e-06	0.000168	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.05e-06	0.000168	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.92e-06	0.000165	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.9e-06	0.000164	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.89e-06	0.000164	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.89e-06	0.000164	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.88e-06	0.000164	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.85e-06	0.000163	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.83e-06	0.000162	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.82e-06	0.000162	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.8e-06	0.000162	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.8e-06	0.000162	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.74e-06	0.00016	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.72e-06	0.00016	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.64e-06	0.000158	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.61e-06	0.000157	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.58e-06	0.000156	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.57e-06	0.000156	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.55e-06	0.000156	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.51e-06	0.000155	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.48e-06	0.000154	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.37e-06	0.000151	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.34e-06	0.000151	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.33e-06	0.00015	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.33e-06	0.00015	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.27e-06	0.000149	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.26e-06	0.000149	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.25e-06	0.000149	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.13e-06	0.000146	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.03e-06	0.000143	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6e-06	0.000143	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6e-06	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.9e-06	0.00014	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.9e-06	0.00014	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.83e-06	0.000139	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.78e-06	0.000137	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.78e-06	0.000137	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.74e-06	0.000137	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.74e-06	0.000136	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.71e-06	0.000136	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.7e-06	0.000135	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.69e-06	0.000135	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.66e-06	0.000134	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.62e-06	0.000134	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.57e-06	0.000132	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.54e-06	0.000132	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.52e-06	0.000131	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.49e-06	0.00013	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.41e-06	0.000129	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.37e-06	0.000128	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.32e-06	0.000127	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.3e-06	0.000126	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.3e-06	0.000126	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.29e-06	0.000126	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.25e-06	0.000125	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.22e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.21e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.2e-06	0.000124	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.19e-06	0.000123	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.17e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.14e-06	0.000122	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.11e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.1e-06	0.000121	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.98e-06	0.000118	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.89e-06	0.000116	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.84e-06	0.000115	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.84e-06	0.000115	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.78e-06	0.000114	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.77e-06	0.000113	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.74e-06	0.000113	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.68e-06	0.000111	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.67e-06	0.000111	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.63e-06	0.00011	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.51e-06	0.000107	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.44e-06	0.000106	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.39e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.37e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.35e-06	0.000103	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.34e-06	0.000103	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.22e-06	0.0001	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.2e-06	9.98e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.18e-06	9.94e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.09e-06	9.72e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.04e-06	9.6e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.04e-06	9.59e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.02e-06	9.55e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.01e-06	9.55e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.84e-06	9.14e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.7e-06	8.81e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.69e-06	8.78e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.65e-06	8.67e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.57e-06	8.49e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.56e-06	8.47e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.54e-06	8.43e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.54e-06	8.42e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.49e-06	8.29e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.41e-06	8.12e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.39e-06	8.07e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.35e-06	7.96e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.32e-06	7.89e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.17e-06	7.54e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.13e-06	7.44e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.08e-06	7.32e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.01e-06	7.17e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.8e-06	6.66e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.32e-06	5.51e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.85e-06	4.4e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	3.39e-05	CbGpPWpGaD
